Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of Oral Glycopyrrolate Liquid to Manage Problem Drooling Associated With Cerebral Palsy or Other Neurologic Conditions in Children
This study has been completed.
Study NCT00425087   Information provided by ResearchPoint
First Received: January 18, 2007   Last Updated: February 5, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sialorrhea
Cerebral Palsy
Neurological Condition
Mental Retardation
Additional conditions recognized in this trial
Paralysis
More general conditions related to this trial
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Mental Disorders
Mental Disorders Diagnosed in Childhood
Mouth Diseases
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Salivary Gland Diseases
Signs and Symptoms
Stomatognathic Diseases
Interventions listed in this trial
Oral Glycopyrrolate Liquid
Additional drug interventions recognized in this trial
Glycopyrrolate
More general drug interventions related to this trial
Adjuvants, Anesthesia
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
ResearchPoint
Sciele Pharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services